These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6341383)
1. Development of a serum-free medium which supports the long-term growth of human and nonhuman primate lymphoid cells. Brown RL; Griffith RL; Neubauer RH; Rabin H J Cell Physiol; 1983 May; 115(2):191-8. PubMed ID: 6341383 [TBL] [Abstract][Full Text] [Related]
2. Clonal growth of lymphoid cells in serum-free media requires elimination of H2O2 toxicity. Darfler FJ; Insel PA J Cell Physiol; 1983 Apr; 115(1):31-6. PubMed ID: 6833406 [TBL] [Abstract][Full Text] [Related]
3. Effect of IL-6 on proliferation and IG production of human EBV-transformed cell lines in serum free culture media. Jochems GJ; Jordens R; van Lier RA; Zeijlemaker WP Dev Biol Stand; 1990; 71():57-63. PubMed ID: 2169441 [TBL] [Abstract][Full Text] [Related]
4. The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23). Callard RE; Lau YL; Shields JG; Smith SH; Cairns J; Flores-Romo L; Gordon J Immunology; 1988 Nov; 65(3):379-84. PubMed ID: 3145248 [TBL] [Abstract][Full Text] [Related]
5. Development of a serum-free and heat-sterilizable medium and continuous high-density cell culture. Minamoto Y; Ogawa K; Abe H; Iochi Y; Mitsugi K Cytotechnology; 1991; 5 Suppl 2():S35-51. PubMed ID: 1367253 [TBL] [Abstract][Full Text] [Related]
6. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Brower M; Carney DN; Oie HK; Gazdar AF; Minna JD Cancer Res; 1986 Feb; 46(2):798-806. PubMed ID: 3940644 [TBL] [Abstract][Full Text] [Related]
7. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells. Kryworuckho M; Diaz-Mitoma F; Kumar A Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880 [TBL] [Abstract][Full Text] [Related]
8. Interleukin 2 production by a marmoset B cell line. Brent LH; Miyawaki T; Everson MP; Butler JL Eur J Immunol; 1990 May; 20(5):1125-9. PubMed ID: 2162776 [TBL] [Abstract][Full Text] [Related]
9. [The cultivation of mouse and human lymphoid cells on serum-free media]. Nikolaenko NS; Tsupkina NV; Pinaev GP Tsitologiia; 1992; 34(8):88-95. PubMed ID: 1293879 [TBL] [Abstract][Full Text] [Related]
10. Growth and differentiation of human and murine erythroleukemia cell lines in serum-free synthetic medium. Pessano S; McNab A; Rovera G Cancer Res; 1981 Sep; 41(9 Pt 1):3592-6. PubMed ID: 7020933 [TBL] [Abstract][Full Text] [Related]
11. Induction of phenotypic differentiation, interleukin 2 production, and PHA responsiveness of "immature" human thymocytes by interleukin 1 and phorbol ester. de Vries JE; Vyth-Dreese FA; Figdor CG; Spits H; Leemans JM; Bont WS J Immunol; 1983 Jul; 131(1):201-6. PubMed ID: 6408170 [TBL] [Abstract][Full Text] [Related]
12. Transferrin-like autocrine growth factor, derived from T-lymphoma cells, that inhibits normal T-cell proliferation. Morrone G; Corbo L; Turco MC; Pizzano R; De Felice M; Bridges S; Venuta S Cancer Res; 1988 Jun; 48(12):3425-9. PubMed ID: 3259467 [TBL] [Abstract][Full Text] [Related]
13. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2. Duncan MR; George FW; Hadden JW J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367 [TBL] [Abstract][Full Text] [Related]
14. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1. Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051 [TBL] [Abstract][Full Text] [Related]
15. Clonal growth of human acute myeloid leukemia cells (ML-1 and HL-60) in serum-free agar medium. Taketazu F; Kubota K; Kajigaya S; Shionoya S; Motoyoshi K; Saito M; Takaku F; Miura Y Cancer Res; 1984 Feb; 44(2):531-5. PubMed ID: 6607105 [TBL] [Abstract][Full Text] [Related]
16. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Kube D; Platzer C; von Knethen A; Straub H; Bohlen H; Hafner M; Tesch H Cytokine; 1995 Jan; 7(1):1-7. PubMed ID: 7749063 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes. Fior R; Vita N; Raphael M; Minty A; Maillot MC; Crevon MC; Caput D; Biberfeld P; Ferrara P; Galanaud P Eur Cytokine Netw; 1994; 5(6):593-600. PubMed ID: 7727691 [TBL] [Abstract][Full Text] [Related]
18. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts. Torsteinsdottir S; Masucci MG; Szigeti R; Bishara A; Brautbar C; Klein G; Klein E Mol Biol Med; 1984 Aug; 2(4):285-99. PubMed ID: 6443579 [TBL] [Abstract][Full Text] [Related]
19. Factors involved in the control of proliferation of bovine corneal endothelial cells maintained in serum-free medium. Giguère L; Cheng J; Gospodarowicz D J Cell Physiol; 1982 Jan; 110(1):72-80. PubMed ID: 6461663 [TBL] [Abstract][Full Text] [Related]
20. Human immunoglobulin biosynthesis in a serum-free medium. Sharath MD; Rinderknecht SB; Weiler JM J Lab Clin Med; 1984 May; 103(5):739-48. PubMed ID: 6715953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]